Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 5/2009

Ausgabe 5/2009

Inhaltsverzeichnis ( 22 Artikel )

01.10.2009 | Commentary | Ausgabe 5/2009

Physical activity and breast cancer survival

Adeyemi A Ogunleye, Michelle D Holmes

01.10.2009 | Erratum | Ausgabe 5/2009

Erratum to: Genomic profiling of breast tumours in relation to BRCAabnormalities and phenotypes

Olafur Andri Stefansson, Jon Gunnlaugur Jonasson, Oskar Thor Johannsson, Kristrun Olafsdottir, Margret Steinarsdottir, Sigridur Valgeirsdottir, Jorunn Erla Eyfjord

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

Magnetic resonance imaging of the natural history of in situmammary neoplasia in transgenic mice: a pilot study

Sanaz A Jansen, Suzanne D Conzen, Xiaobing Fan, Erica J Markiewicz, Gillian M Newstead, Gregory S Karczmar

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ

Fariba Behbod, Frances S Kittrell, Heather LaMarca, David Edwards, Sofia Kerbawy, Jessica C Heestand, Evelin Young, Purna Mukhopadhyay, Hung-Wen Yeh, D Craig Allred, Min Hu, Kornelia Polyak, Jeffrey M Rosen, Daniel Medina

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients

Yi Yan, George P Skliris, Carla Penner, Shilpa Chooniedass-Kothari, Charlton Cooper, Zoann Nugent, Anne Blanchard, Peter H Watson, Yvonne Myal, Leigh C Murphy, Etienne Leygue

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis

Michael K Wendt, William P Schiemann

01.10.2009 | Review | Ausgabe 5/2009

Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development

Jacqueline Whyte, Orla Bergin, Alessandro Bianchi, Sara McNally, Finian Martin

01.10.2009 | Editorial | Ausgabe 5/2009

Development of 'synthetic lethal' strategies to target BRCA1-deficient breast cancer

Max S Wicha

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

Silvia Darb-Esfahani, Sibylle Loibl, Berit M Müller, Marc Roller, Carsten Denkert, Martina Komor, Karsten Schlüns, Jens Uwe Blohmer, Jan Budczies, Bernd Gerber, Aurelia Noske, Andreas du Bois, Wilko Weichert, Christian Jackisch, Manfred Dietel, Klaus Richter, Manfred Kaufmann, Gunter von Minckwitz

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells

Heather C Workman, Jamie K Miller, Ellen Q Ingalla, Rouminder P Kaur, Diane I Yamamoto, Laurel A Beckett, Lawrence JT Young, Robert D Cardiff, Alexander D Borowsky, Kermit L Carraway, Colleen Sweeney, Kermit L Carraway III

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer

Heidi Schwarzenbach, Klaus Pantel, Birthe Kemper, Cord Beeger, Friedrich Otterbach, Rainer Kimmig, Sabine Kasimir-Bauer

01.10.2009 | Editorial | Ausgabe 5/2009

Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells

Manfred Schmitt, John A Foekens

01.10.2009 | Review | Ausgabe 5/2009

Key signalling nodes in mammary gland development and cancer: Myc

Nancy E Hynes, Tina Stoelzle

01.10.2009 | Editorial | Ausgabe 5/2009

Notch versus the proteasome: what is the target of γ-secretase inhibitor-I?

Anthony G Clementz, Clodia Osipo

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice

Marina Simian, Mina J Bissell, Mary Helen Barcellos-Hoff, Gopalan Shyamala

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer

Mark D Pegram, Virginia F Borges, Nuhad Ibrahim, Jyotsna Fuloria, Charles Shapiro, Susan Perez, Karen Wang, Franziska Schaedli Stark, Nigel Courtenay Luck

01.10.2009 | Review | Ausgabe 5/2009

Update on the use of aromatase inhibitors in early-stage breast cancer

Georgios Kesisis, Andreas Makris, David Miles

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

BU-32: a novel proteasome inhibitor for breast cancer

Joseph K Agyin, Bindu Santhamma, Hareesh B Nair, Sudipa S Roy, Rajeshwar R Tekmal

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study

Szu-Min Hsieh, Maxime P Look, Anieta M Sieuwerts, John A Foekens, Kent W Hunter

01.10.2009 | Review | Ausgabe 5/2009

Androgens and the breast

Constantine Dimitrakakis, Carolyn Bondy

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers

Susan L Neuhausen, Sean Brummel, Yuan Chun Ding, Christian F Singer, Georg Pfeiler, Henry T Lynch, Katherine L Nathanson, Timothy R Rebbeck, Judy E Garber, Fergus Couch, Jeffrey Weitzel, Steven A Narod, Patricia A Ganz, Mary B Daly, Andrew K Godwin, Claudine Isaacs, Olufunmilayo I Olopade, Gail Tomlinson, Wendy S Rubinstein, Nadine Tung, Joanne L Blum, Daniel L Gillen

01.10.2009 | Research article | Ausgabe 5/2009 Open Access

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Richard S Finn, Judy Dering, Dylan Conklin, Ondrej Kalous, David J Cohen, Amrita J Desai, Charles Ginther, Mohammad Atefi, Isan Chen, Camilla Fowst, Gerret Los, Dennis J Slamon

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise